Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists IIJason M Elliott, Robert W Carling, Gary G Chicchi, et al.Bioorganic & Medicinal Chemistry Letters|July 23, 2015
Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonistsZhong Lai, Shuwen He, Edward C Sherer, et al.Bioorganic & Medicinal Chemistry Letters|July 20, 2007
The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidinePeter Lin, Lehua Chang, Robert J Devita, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 AntagonistAlexander Pasternak, Zhe Feng, Reynalda de Jesus, et al.Bioorganic & Medicinal Chemistry Letters|July 13, 2006
Cyclopentane-based human NK1 antagonists. Part 2: development of potent, orally active, water-soluble derivativesLaura C Meurer, Paul E Finke, Karen A Owens, et al.Journal of Medicinal Chemistry|April 10, 2009
Potent, brain-penetrant, hydroisoindoline-based human neurokinin-1 receptor antagonistsJinlong Jiang, Jaime L Bunda, Geoge A Doss, et al.Diabetes|July 16, 2009
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in miceAlessandro Pocai, Paul E Carrington, Jennifer R Adams, et al.ACS Medicinal Chemistry Letters|June 20, 2014
Diamine Derivatives as Novel Small-Molecule, Potent, and Subtype-Selective Somatostatin SST3 Receptor AgonistsDerun Li, Zhicai Wu, Yang Yu, et al.ACS Medicinal Chemistry Letters|July 23, 2014
Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonistsShuwen He, Zhong Lai, Zhixiong Ye, et al.ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 DiabetesShrenik K Shah, Shuwen He, Liangqin Guo, et al.Pageof 4